» Articles » PMID: 18288619

Recent Progress on Tissue-resident Adult Stem Cell Biology and Their Therapeutic Implications

Overview
Journal Stem Cell Rev
Specialty Cell Biology
Date 2008 Feb 22
PMID 18288619
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Recent progress in the field of the stem cell research has given new hopes to treat and even cure diverse degenerative disorders and incurable diseases in human. Particularly, the identification of a rare population of adult stem cells in the most tissues/organs in human has emerged as an attractive source of multipotent stem/progenitor cells for cell replacement-based therapies and tissue engineering in regenerative medicine. The tissue-resident adult stem/progenitor cells offer the possibility to stimulate their in vivo differentiation or to use their ex vivo expanded progenies for cell replacement-based therapies with multiple applications in human. Among the human diseases that could be treated by the stem cell-based therapies, there are hematopoietic and immune disorders, multiple degenerative disorders, such as Parkinson's and Alzheimer's diseases, type 1 or 2 diabetes mellitus as well as eye, liver, lung, skin and cardiovascular disorders and aggressive and metastatic cancers. In addition, the genetically-modified adult stem/progenitor cells could also be used as delivery system for expressing the therapeutic molecules in specific damaged areas of different tissues. Recent advances in cancer stem/progenitor cell research also offer the possibility to targeting these undifferentiated and malignant cells that provide critical functions in cancer initiation and progression and disease relapse for treating the patients diagnosed with the advanced and metastatic cancers which remain incurable in the clinics with the current therapies.

Citing Articles

Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers.

Luo Y, Liang H Genome Med. 2024; 16(1):124.

PMID: 39468667 PMC: 11514945. DOI: 10.1186/s13073-024-01393-6.


Mesenchymal Stromal Cells Derived from Canine Adipose Tissue: Evaluation of the Effect of Different Shipping Vehicles Used for Clinical Administration.

Andreoli V, Berni P, Conti V, Ramoni R, Basini G, Grolli S Int J Mol Sci. 2024; 25(6).

PMID: 38542399 PMC: 10970639. DOI: 10.3390/ijms25063426.


Harnessing the Therapeutic Potential of Stem Cells in the Management of Chronic Obstructive Pulmonary Disease: A Comprehensive Review.

Singh P, Singh P, Anjankar A Cureus. 2023; 15(8):e44498.

PMID: 37711945 PMC: 10497883. DOI: 10.7759/cureus.44498.


Endometrial stem/progenitor cells: Properties, origins, and functions.

Hong I Genes Dis. 2023; 10(3):931-947.

PMID: 37396532 PMC: 10308170. DOI: 10.1016/j.gendis.2022.08.009.


Application of low-intensity pulsed ultrasound on tissue resident stem cells: Potential for ophthalmic diseases.

Lin Z, Gao L, Hou N, Zhi X, Zhang Y, Che Z Front Endocrinol (Lausanne). 2023; 14:1153793.

PMID: 37008913 PMC: 10063999. DOI: 10.3389/fendo.2023.1153793.


References
1.
Schier S, Wright N . Stem cell relationships and the origin of gastrointestinal cancer. Oncology. 2005; 69 Suppl 1:9-13. DOI: 10.1159/000086625. View

2.
Braga L, Rosa K, Rodrigues B, Malfitano C, Camassola M, Chagastelles P . Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2007; 35(2):113-9. DOI: 10.1111/j.1440-1681.2007.04820.x. View

3.
Andrade C, Wong A, Waddell T, Keshavjee S, Liu M . Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol. 2006; 292(2):L510-8. DOI: 10.1152/ajplung.00175.2006. View

4.
Wilson A, Trumpp A . Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006; 6(2):93-106. DOI: 10.1038/nri1779. View

5.
Wu Z, Hui G, Lu Y, Wu X, Guo L . Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury. Chin Med J (Engl). 2007; 119(24):2101-7. View